BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11437625)

  • 1. The 'number needed to treat' with Levetiracetam (LEV): comparison with the other new antiepileptic drugs (AEDs).
    van Rijckevorsel K; Boon PA
    Seizure; 2001 Apr; 10(3):235-6. PubMed ID: 11437625
    [No Abstract]   [Full Text] [Related]  

  • 2. A new antiepileptic drug.
    Shorvon SD; van Rijckevorsel K
    J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):426-9. PubMed ID: 11909894
    [No Abstract]   [Full Text] [Related]  

  • 3. Levetiracetam.
    Krishna K; Raut AL; Gohel KH; Dave P
    J Assoc Physicians India; 2011 Oct; 59():656-8. PubMed ID: 22479748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam: treatment in epilepsy.
    Ben-Menachem E
    Expert Opin Pharmacother; 2003 Nov; 4(11):2079-88. PubMed ID: 14596661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacology and clinical results of levetiracetam (E Keppra(®) Tablets), a new antiepileptic drug].
    Ishii Y; Tanaka T
    Nihon Yakurigaku Zasshi; 2011 Feb; 137(2):95-102. PubMed ID: 21321459
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis.
    Luszczki JJ; Andres MM; Czuczwar P; Cioczek-Czuczwar A; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2006 Jan; 47(1):10-20. PubMed ID: 16417526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology of parenteral use of antiepileptic drugs.
    Bialer M
    Epilepsia; 2007; 48 Suppl 8():46-8. PubMed ID: 18329998
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
    Otoul C; De Smedt H; Stockis A
    Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
    Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
    Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam: a comprehensive review.
    Crepeau AZ; Treiman DM
    Expert Rev Neurother; 2010 Feb; 10(2):159-71. PubMed ID: 20136375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam: a new therapeutic option for refractory epilepsy.
    Pinto A; Sander JW
    Int J Clin Pract; 2003 Sep; 57(7):616-21. PubMed ID: 14529064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?
    Klitgaard H
    Epilepsia; 2001; 42 Suppl 4():13-8. PubMed ID: 11564119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary efficacy of levetiracetam in monotherapy.
    Ben-Menachem E
    Epileptic Disord; 2003 May; 5 Suppl 1():S51-5. PubMed ID: 12915342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate.
    Gomer B; Wagner K; Frings L; Saar J; Carius A; Härle M; Steinhoff BJ; Schulze-Bonhage A
    Epilepsy Behav; 2007 May; 10(3):486-94. PubMed ID: 17409025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
    Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
    Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piracetam and levetiracetam: close structural similarities but different pharmacological and clinical profiles.
    Genton P; Van Vleymen B
    Epileptic Disord; 2000 Jun; 2(2):99-105. PubMed ID: 10954241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
    Kaminski RM; Matagne A; Patsalos PN; Klitgaard H
    Epilepsia; 2009 Mar; 50(3):387-97. PubMed ID: 18627416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials.
    Gidal BE; Baltès E; Otoul C; Perucca E
    Epilepsy Res; 2005; 64(1-2):1-11. PubMed ID: 15823510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of levetiracetam efficacy in epileptic syndromes with continuous spikes-waves during slow sleep.
    Atkins M; Nikanorova M
    Seizure; 2011 Oct; 20(8):635-9. PubMed ID: 21752673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.